AEON Biopharma, Inc.
Veridion Score
Composite trend over time
Why is AEON moving today?
AEON Biopharma Inc is a biopharmaceutical company focused on the development of ABP-450 (prabotulinumtoxinA), a biosimilar to Botox (onabotulinumtoxinA), for therapeutic indications. The company is advancing ABP-450 through the biosimilar regulatory pathway and holds development and commercialization rights across multiple international markets.
Reported fields plus Veridion-computed history. Unsourced tiles are omitted.
Warehouse intelligence for AEON.
AEON insider activity
AEON Biopharma, Inc.
No multi-insider buying cluster in the last 90 days
Mixed: Not disclosed across loaded Form 4 rows.
Loaded official disclosures do not show all three sources aligned on this ticker.
The current Form 4 feed did not return value-bearing open-market rows for AEON.
AEON contract awards, year to date.
Public federal awards linked to this ticker.
AEON lobbying filings, year to date.
Registered lobbying filings matched to AEON Biopharma, Inc..